Pharmacy Practice

Pharmacists Now Can Tell Insured Patients About Lower-Cost Option

Cheryl Thompson
Cheryl A. Thompson Director News Center Published: October 10, 2018

President Donald J. Trump speaks in the White House Roosevelt Room during the signing ceremony for bills banning so-called gag clauses in contracts with pharmacies.President Donald J. Trump today, in a ceremony attended by ASHP CEO Paul W. Abramowitz, signed legislation outlawing the insurance clauses that have been preventing pharmacists from telling patients whenever they can pay less for a prescription medication by buying it on their own.

Trump signed two bipartisan bills into law: “Know the Lowest Price Act of 2018,” S. 2553; and “Patient Right to Know Drug Prices Act,” S. 2554.

S. 2553 applies to Medicare prescription drug plan sponsors and Medicare Advantage organizations, starting with plan year 2020.

S. 2554 pertains to group health plans and to insurers that sell health coverage policies to groups or individuals.


“These clauses prevent pharmacists from telling patients about more affordable options for prescription drugs,” Trump said in describing the subject of the bills. “Today, Congress is building on my administration’s actions with legislation — very strong legislation — to completely end these unjust gag clauses once and for all.”

Passage of the bills, said Department of Health and Human Services Secretary (HHS) Alex M. Azar II, shows that the two major political parties can act in a bipartisan way “to get drug prices down.”

Both bills were introduced on March 14 and passed by the Senate in September. The House of Representatives, by voice votes, passed both bills on September 25.

S. 2553 goes a step further than the action proposed by HHS in American Patients First: The Trump Administration Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs, released in May.

In the blueprint, the department stated it may prohibit “pharmacy gag clauses” in Medicare Part D prescription drug program contracts. Less than a week after release of the blueprint, Centers for Medicare & Medicaid Services Administrator Seema Verma issued a memo telling Part D plan sponsors that her agency “finds any form of ‛gag clauses’ unacceptable and contrary to our efforts to promote drug price transparency and lower drug prices.” The law signed by the president today also applies to contracts by Medicare Advantage organizations.

ASHP CEO Paul W. Abramowitz shakes hands with President Donald J. Trump before the signing ceremony.
Posted October 10, 2018

Advance Your Professional Development

View Other Products

Free Board Exam Prep Resources

The Review & Recertification Reward Program (RRRP) includes free access to exam preparation material + enrollment in a recertification plan billed monthly ($10) during your initial recertification cycle. For ASHP members only.

Learn More
Review & Recertification Reward Program (RRRP)

New Edition Available to Order

AHFS Drug Information® 2024 contains the most dependable drug information available—all in one place. It is the most comprehensive evidence-based source of drug information complete with therapeutic guidelines and off-label uses.

Order Today
AHFS 2024 Drug Information